Inrig Jula 4
4 · Travere Therapeutics, Inc. · Filed Sep 10, 2024
Insider Transaction Report
Form 4
Inrig Jula
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2024-09-10$12.98/sh−684$8,878→ 61,949 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted March 15, 2024 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units that vested on September 5, 2024.